Paul England discusses the extent to which intellectual property rights are harmonising to meet the challenges of a globalised life sciences industry.
A legal toolkit for life sciences companies and their investors providing access to information on:
Wolfgang Rehmann and Diana Heimhalt discuss developments since phase 1 of the European Medicines Agency´s (EMA) new policy on publication of clinical trial data entered into force...read more
Nikol Davies and Michelle Williamson explain the UK Government's consultation proposing changes to the design of the Patent Box...read more
Alex Walker discusses the decision in Novartis Europharm Ltd v the European Commission regarding regulatory data protection periods...read more
Receive our monthly newsletter keeping you updated on recent developments and events in the Life Sciences sector...